This jewellery brand is a name to watch on the London scene. Here, we celebrate their milestone new collection, The Origins.

Novartis has bulked up its cardiology pipeline with a $1.4 billion takeover of Tourmaline Bio and its phase 3-ready drug for atherosclerotic cardiovascular disease (ASCVD). The Swiss pharma group has ...

Tourmaline Oil Corp. is an oil and natural gas company, which engages in the acquisition, exploration, development, and production of petroleum and natural gas properties. It focuses on its program in ...

Vibrant and nuanced coloured gemstone jewellery reflects the changing season, but is also becoming a permanent addition to ...